Trial Details

Not Recruiting
Basic Information
Clinical ID c5115
Identifier EUCTR2011-004561-33-AT
Trial Title A randomized, controlled, single-blinded, phase II study to investigate the safety and efficacy of intravenous infusions of FERINJECT versus placebo on platelet activity in patients with iron deficiency and chronic inflammatory bowel disease. The ThromboA
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions iron deficiency in chronic inflammatory bowel disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: FerinjectProduct Name: FerinjectPharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: ferric carboxymaltoseCAS Number: 9007-72-01Current Sponsor code: Vifor intOther descriptive name: ferinj
Participant Information
Sponsor Medizinische Universit Wien, Klinik f Innere Medizin III, Abteilung f Gastroenterologie und Hepatologie
City NULL
Country/Region Austria
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL